特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
940945

ポイントオブケア (POC) 検査の世界市場:2022 年

Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022

出版日: | 発行: RNCOS E-Services Pvt. Ltd. | ページ情報: 英文 95 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
ポイントオブケア (POC) 検査の世界市場:2022 年
出版日: 2020年06月01日
発行: RNCOS E-Services Pvt. Ltd.
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポイントオブケア検査装置は現在、多くの病状に応用されています。分散的な、患者中心の医療を提供するための救命救急診療分野での使用が増加しているため、 世界のポイントオブケア検査市場は急速な成長が見込まれます。 2022年までに、 世界のポイントオブケア検査市場は300億米ドルに達すると予測されています。

当レポートでは、世界のポイントオブケア (POC) 検査市場について調査分析し、課題、促進要因、開発、詳細な市場分析について、体系的な情報を提供しています。

目次

第1章 アナリストの見解

第2章 調査手法

第3章 体外診断市場概要

  • イントロダクション
  • 体外診断とは
  • 市場規模と成長

第4章 ポイントオブケア診断:概要

第5章 市場力学

  • 市場成長要因
    • 感染症および生活習慣病の高い有病率
    • 家庭ベースのポイントオブケア診断の使用の増加
    • 政府の取り組み
    • 技術の進歩
    • FDA承認の増加
    • 熟練したラボスタッフの不足
    • POCTに関する意識の高まり
  • 市場の阻害要因
    • 製品のリコール
    • 規制基準の欠如
    • データ管理とコネクティビティ
  • 市場機会
    • 物理的ロボットテレプレゼンス
    • モバイルデバイスに関連するスマートバーチャルアシスタント

第6章 ポイントオブケア検査市場の展望2022

第7章 ポイントオブケア検査市場、製品別

  • イントロダクション
    • グルコースモニタリングキット
    • 血液ガスおよび電解質アナライザー
    • 妊娠および不妊検査キット
    • 心臓マーカー
    • 感染症検査キット
    • 薬物乱用検査キット
    • その他

第8章 地域別ポイントオブケア検査市場

  • イントロダクション
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第9章 業界動向と発展

  • 現場でケアを提供するポータブル超音波
  • POCT業界をクラウド化するマイクロ流体技術

第10章 企業プロファイル

  • Becton, Dickinson and Company
  • Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • Siemens Healthineers
  • Danaher Corporation
  • Abbott Laboratories
  • Johnson & Johnson
  • OraSure Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Medtronic plc
図表

List of Figures:

  • Figure 3-1: Global - Diabetes Incidence (Million), 2015 & 2040
  • Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Share of Point-of-Care Testing in the IVD Market (%), 2017
  • Figure 6-2: Global - Share of Point-of-Care Testing in the IVD Market (%), 2022
  • Figure 6-3: Global - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 7-1: Global - Point-of-Care Testing Market by Product (%), 2017
  • Figure 7-2: Global - Point-of-Care Testing Market by Product (%), 2022
  • Figure 7-3: Global - Glucose Monitoring Kits Market (Billion US$), 2017-2022
  • Figure 7-4: Global - Blood Gas and Electrolyte Analyzers Market (Billion US$), 2017-2022
  • Figure 7-5: Global - Pregnancy & Fertility Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-6: Global - Cardiac Markers Market (Billion US$), 2017-2022
  • Figure 7-7: Global - Infectious Diseases Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-8: Global - Drug-of-Abuse Testing Kits Market (Billion US$), 2017-2022
  • Figure 7-9: Global - Other POC Testing Kits Market (Billion US$), 2017-2022
  • Figure 8-1: Global - Point-of-Care Testing Market by Region (%), 2017
  • Figure 8-2: Global - Point-of-Care Testing Market by Region (%), 2022
  • Figure 8-3: North America - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-4: Europe - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-5: Asia Pacific - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 8-6: Rest of the World - Point-of-Care Testing Market (Billion US$), 2017-2022
  • Figure 10-1: Becton, Dickinson and Company - Revenue by Segment (%), 2019
  • Figure 10-2: Becton, Dickinson and Company - Revenue by Geography (%), 2019
  • Figure 10-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2019
  • Figure 10-4: F.Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2019
  • Figure 10-5: Danaher Corporation - Breakup of Sales by Business Segments (%), 2019
  • Figure 10-6: Danaher Corporation - Breakup of Sales by Geography (%), 2019
  • Figure 10-7: Abbott Laboratories - Revenue Breakup by Segments (%), 2019
  • Figure 10-8: Abbott Laboratories - Revenue Breakup by Geography (%), 2019
  • Figure 10-9: Johnson & Johnson - Revenue by Segment (%), 2019
  • Figure 10-10: Johnson & Johnson - Medical Devices Revenue by Segment (%), 2019
  • Figure 10-11: Johnson & Johnson - Revenue by Geography (%), 2019
  • Figure 10-12: Johnson & Johnson - Medical Devices Revenue by Geography (%), 2019
  • Figure 10-13: OraSure Technologies, Inc. - Revenue by Segment (%), 2019
  • Figure 10-14: OraSure Technologies, Inc. - OSUR Revenue by Segment (%), 2019
  • Figure 10-15: OraSure Technologies, Inc. - Revenue by Geography (%), 2019
  • Figure 10-16: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2019
  • Figure 10-17: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2019
  • Figure 10-18: Medtronic plc - Breakup of Revenue by Business Segments (%), 2019
  • Figure 10-19: Medtronic plc - Breakup of Revenue by Geography (%), 2019

List of Tables:

  • Table 7-1: Frequently used Point-of-Care Glucose Monitoring Devices
  • Table 7-2: Differences between the Blood Gas Analyzer and Auto-Analyzer
  • Table 7-3: Home Pregnancy Test Kits
  • Table 10-1: Becton, Dickinson and Company - Key Financials (Million US$), 2017-2019
  • Table 10-2: Becton, Dickinson and Company - Product Portfolio for Point-of-Care Testing
  • Table 10-3: F. Hoffmann-La Roche Ltd. - Key Financials (Billion US$), 2017-2019
  • Table 10-4: Roche Diagnostics - Product Portfolio for Point-of-Care Testing
  • Table 10-5: Siemens Healthineers - Key Financials (Million US$), 2017-2019
  • Table 10-6: Siemens Healthineers - Product Portfolio for Point-of-Care Testing
  • Table 10-7: Danaher Corporation - Key Financials (Million US$), 2017-2019
  • Table 10-8: Danaher Corporation - Product Portfolio for Point-of-Care Testing
  • Table 10-9: Abbott Laboratories - Key Financials (Million US$), 2017-2019
  • Table 10-10: Abbott Laboratories - Product Portfolio for Point-of-Care Testing
  • Table 10-11: Johnson & Johnson - Key Financials (Million US$), 2017-2019
  • Table 10-12: Johnson & Johnson - Product Portfolio for Point-of-Care Testing
  • Table 10-13: OraSure Technologies, Inc. - Key Financials (Million US$), 2017-2019
  • Table 10-14: OraSure Technologies, Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-15: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2017-2019
  • Table 10-16: Thermo Fisher Scientific Inc. - Product Portfolio for Point-of-Care Testing
  • Table 10-17: Medtronic plc - Key Financials (Billion US$), 2017-2019
  • Table 10-18: Medtronic plc - Product Portfolio for Point-of-Care Testing
目次

Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.

As per RNCOS report "Global Point-of-Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022", the global Point-of-Care testing market is anticipated to witness a rapid growth during 2017-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.

Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.

The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2017 due to rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2017, North America accounted for the largest share.

The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.

Table of Contents

1. Analyst View

2. Research Methodology

3. In Vitro Diagnostic Market Overview

  • 3.1 Introduction
  • 3.2 What is In Vitro Diagnostics?
  • 3.3 Market Size and Growth

4. Point-of-Care Diagnostics: An Overview

5. Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Prevalence of Infectious and Lifestyle Related Diseases
    • 5.1.2 Rising Use of Home Based Point-of-Care Diagnostics
    • 5.1.3 Government Initiatives
    • 5.1.4 Technological Advancements
    • 5.1.5 Rising FDA Approvals
    • 5.1.6 Lack of Skilled Lab Personnel
    • 5.1.7 Rising Awareness about POCT
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Lack of Regulatory Standards
    • 5.2.3 Data Management & Connectivity
  • 5.3 Market Opportunities
    • 5.3.1 Physical Robotic Telepresence
    • 5.3.2 Smart Virtual Assistant in Association with Mobile Devices

6. Point-of-Care Testing Market Outlook 2022

7. Point-of-Care Testing Market, By Product

  • 7.1 Introduction
    • 7.1.1 Glucose Monitoring Kits
    • 7.1.2 Blood Gas and Electrolyte Analyzers
    • 7.1.3 Pregnancy & Fertility Testing Kits
    • 7.1.4 Cardiac Markers
    • 7.1.5 Infectious Diseases Testing Kits
    • 7.1.6 Drug-of-Abuse Testing Kits
    • 7.1.7 Others

8. Point-of-Care Testing Market, By Region

  • 8.1 Introduction
    • 8.1.1 North America
    • 8.1.2 Europe
    • 8.1.3 Asia Pacific
    • 8.1.4 Rest of the World

9. Industry Trends and Developments

  • 9.1 Portable Ultrasound Providing Care on Site
  • 9.2 Microfluidics Technology Crowding the POCT Industry

10. Company Profiles

  • 10.1 Becton, Dickinson and Company
  • 10.2 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • 10.3 Siemens Healthineers
  • 10.4 Danaher Corporation
  • 10.5 Abbott Laboratories
  • 10.6 Johnson & Johnson
  • 10.7 OraSure Technologies, Inc.
  • 10.8 Thermo Fisher Scientific Inc.
  • 10.9 Medtronic plc
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.